Opus Point Partners, LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Opus Point Partners, LLC
CIK #0001503454, 0001600175
Sector Form 13F Holdings Value ($M)
Mettler Toledo International INC/ 2.3
Bristol Myers Squibb Co 1.7
Illumina Inc 1.4
Vertex Pharmaceuticals Inc / Ma 1.4
ISIS Pharmaceuticals Inc 1.2
Alnylam Pharmaceuticals Inc 1.1
Qiagen NV 1.0
Coronado Biosciences Inc 0.9
Proqr Therapeutics NV 0.8
Incyte Corp 0.8
View All
Holdings by Sector ($M)
190152114763802013201520172020
EDGAR Form CIK 2011 - 2025
3 [0001503454]
SC 13D [0001503454]
SC 13G [0001503454]
13F-HR [0001600175]
Form 13D/13G Filer Form 13D/13G Subject Filed
Opus Point Partners LLC Anthera Pharmaceuticals Inc [2012-08-27]
Opus Point Partners LLC Manhattan Pharmaceuticals Inc [2012-01-10]
Form 3/4/5 Subject 2011 - 2025
National Holdings Corp
Rosenwald Lindsay A MD
Fortress Biotech, Inc.
FBIO Acquisition, Inc.
Weiss Michael S
Opus Point Healthcare Innovations (Offshore) Fund Ltd.
Opus Point Partners, LLC
TG Therapeutics Inc
Terms | Privacy | Guide
tony@aum13f.com